Data Analysis in Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Data Analysis in Clinical Trials in Mexico

Data Analysis in Clinical Trials in Mexico – Advantages of Clinical Trials

In recent years, data analysis has played a pivotal role in transforming the landscape of clinical trials across the globe. Mexico, with its growing prominence in medical research and development, is no exception.

By harnessing the power of data analysis, clinical trials in Mexico are making significant strides towards improving healthcare outcomes, enhancing patient safety, and accelerating the drug development process. In this blog post, we will explore the importance of data analysis in clinical trials specifically in the context of Mexico and how it is shaping the future of healthcare in the country.

Enhancing Trial Design and Planning:

Data analysis plays a crucial role in the initial stages of clinical trial design and planning. Researchers in Mexico leverage historical clinical trial data, population demographics, and epidemiological information to develop robust study protocols.

By analyzing these datasets, researchers can identify relevant patient populations, determine appropriate sample sizes, and estimate statistical power. This enables them to design trials that are scientifically sound, cost-effective, and ethically sound, ensuring that resources are utilized efficiently and effectively.

Improved Patient Recruitment and Retention:

One of the major challenges in conducting clinical trials is patient recruitment and retention. Data analysis helps researchers in Mexico to identify potential trial participants by mining various healthcare databases and electronic medical records.

By analyzing demographic and clinical characteristics, researchers can target specific patient populations, ensuring better representation and diversity. Moreover, data analysis can also help predict patient dropout rates, enabling researchers to implement strategies to improve patient retention throughout the trial duration.

Real-time Monitoring and Safety:

Data analysis plays a vital role in monitoring patient safety during clinical trials. In Mexico, advanced analytical techniques are employed to analyze patient data collected during the trial. By monitoring adverse events, laboratory values, and other relevant safety indicators in real-time, researchers can promptly identify potential risks and intervene if necessary. This not only ensures the well-being of trial participants but also helps maintain the integrity of the trial data.

Data Analysis in clinical trials in Mexico

Data Analysis in Clinical Trials in Mexico

Data Analysis in clinical trials in Mexico

Efficient Data Management:

Large-scale clinical trials generate vast amounts of data, which can be overwhelming to manage and analyze. Data analysis techniques help streamline data management processes in Mexican clinical trials.

From data cleaning and standardization to data integration and quality control, advanced analytical tools ensure that data is accurate, reliable, and readily available for analysis. This allows researchers to derive meaningful insights, make informed decisions, and produce reliable study results.

Statistical Analysis and Interpretation:

Data analysis techniques, such as statistical modeling and machine learning, enable researchers in Mexico to extract valuable insights from clinical trial data. By applying appropriate statistical tests, researchers can assess treatment efficacy, evaluate safety profiles, and identify potential correlations or associations. These insights aid in data interpretation and support evidence-based decision-making in the development of new therapies and treatments.

Post-trial Analysis and Reporting:

Data analysis continues to be valuable even after the completion of a clinical trial. In Mexico, researchers analyze trial data to summarize study findings, assess the overall trial success, and generate reports for regulatory submissions. Additionally, post-trial analysis allows for the identification of potential areas of improvement for future trials, contributing to the continuous enhancement of the clinical research landscape in Mexico.


Data analysis has revolutionized the field of clinical trials in Mexico, empowering researchers and healthcare professionals to make informed decisions, improve patient outcomes, and drive advancements in healthcare. By leveraging data analysis techniques, clinical trials in Mexico can enhance trial design, optimize patient recruitment, ensure patient safety, streamline data management, and derive meaningful insights.

As Mexico continues to foster an environment conducive to medical research, the integration of data analysis will undoubtedly play a pivotal role in shaping the future of clinical trials and healthcare in the country.

Data Analysis in clinical trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Data Analysis in Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Data Analysis in Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Data Analysis in Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Data Analysis in Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Data Analysis in Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Data Analysis in Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Data Analysis in Clinical Trials in Mexico

The Cohortias Team

Data Analysis in Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Data Analysis in Clinical Trials in Mexico

Network & Partnerships